FDA Inspection 1092794 — OHM Pharma, Inc.
The FDA completed an inspection of OHM Pharma, Inc. on May 23, 2019 in Mineral Wells, TX. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- May 23, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mineral Wells, TX (United States)